Primary Biliary Cirrhosis and Autoimmune Hepatitis: Apotopes and Epitopes

Overview

Journal J Gastroenterol

Specialty Gastroenterology

Date 2010 Aug 28

PMID 20798971

Citations 16

Authors

Ana Lleo

Shinji Shimoda

Hiromi Ishibashi

M Eric Gershwin

Affiliations

Soon will be listed here.

Abstract

Autoimmune liver diseases (ALDs) represent a wide spectrum of chronic inflammatory diseases that are characterized by an immune-mediated attack against either hepatocytes (in the case of autoimmune hepatitis types 1 and 2, AIH-1, 2) or cholangiocytes (in primary biliary cirrhosis, PBC). PBC is considered a model autoimmune disease due to the homogeneity of patients, the high specificity of antimitochondrial antibodies (AMAs), and the specificity of biliary epithelial cell (BEC) destruction. It ensues from a multi-lineage loss of tolerance to the E2 component of the pyruvate dehydrogenase complex (PDC-E2). One of the major unanswered questions in the pathogenesis of PBC is the specificity of small intrahepatic bile duct attack while PDC-E2 is present in mitochondria of nucleated cells. Recent findings suggest that the apoptosis of BECs may be of considerable importance for understanding PBC, and that they are more than simply an innocent victim of an immune attack. Rather, they attract immune attack by virtue of the unique biochemical mechanisms by which they handle PDC-E2. The role of apoptotic cells in AIH is not well defined, but advances in the study of autoreactive T cells stem mostly from AIH type 2, where the main autoantigen (CYP2D6) is known, enabling the characterization of antigen-specific immune responses. This review article is intended to provide a critical overview of current evidence on tissue specificity in ALDs, as well as the characteristics of the relevant epitopes and apotopes and their biological and clinical significance.

Citing Articles

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics.

Park J, Kim J, Kim S, Jung J, Jang M, Park S Biomedicines. 2022; 10(6).

PMID: 35740310 PMC: 9220082. DOI: 10.3390/biomedicines10061288.

Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development.

Arsenijevic A, Stojanovic B, Milovanovic J, Arsenijevic D, Arsenijevic N, Milovanovic M Int J Mol Sci. 2020; 21(14).

PMID: 32707678 PMC: 7404314. DOI: 10.3390/ijms21145097.

Abnormal Expression of ERα in Cholangiocytes of Patients With Primary Biliary Cholangitis Mediated Intrahepatic Bile Duct Inflammation.

Cao H, Zhu B, Qu Y, Zhang W Front Immunol. 2019; 10:2815.

PMID: 31867004 PMC: 6907097. DOI: 10.3389/fimmu.2019.02815.

Primary biliary cholangitis: pathogenesis and therapeutic opportunities.

Gulamhusein A, Hirschfield G Nat Rev Gastroenterol Hepatol. 2019; 17(2):93-110.

PMID: 31819247 DOI: 10.1038/s41575-019-0226-7.

Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease.

Palmer M, Regev A, Lindor K, Avigan M, Dimick-Santos L, Treem W Aliment Pharmacol Ther. 2019; 51(1):90-109.

PMID: 31762074 PMC: 6972572. DOI: 10.1111/apt.15579.

References

Larizza D, Calcaterra V, Martinetti M . Autoimmune stigmata in Turner syndrome: when lacks an X chromosome. J Autoimmun. 2009; 33(1):25-30. DOI: 10.1016/j.jaut.2009.03.002. View

Shimoda S, Harada K, Niiro H, Yoshizumi T, Soejima Y, Taketomi A . Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology. 2008; 47(3):958-65. DOI: 10.1002/hep.22102. View

Ma Y, Bogdanos D, Hussain M, Underhill J, Bansal S, Longhi M . Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology. 2006; 130(3):868-82. DOI: 10.1053/j.gastro.2005.12.020. View

Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M . High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus. 1998; 7(2):113-8. DOI: 10.1191/096120398678919804. View

Kawano A, Shimoda S, Kamihira T, Ishikawa F, Niiro H, Soejima Y . Peripheral tolerance and the qualitative characteristics of autoreactive T cell clones in primary biliary cirrhosis. J Immunol. 2007; 179(5):3315-24. DOI: 10.4049/jimmunol.179.5.3315. View

Coppel R, Mackay I, Bass N, Ansari A, Gershwin M . The immunobiology of bile and biliary epithelium. Hepatology. 1999; 30(2):351-7. DOI: 10.1002/hep.510300218. View

Van de Water J, Gershwin M, Leung P, Ansari A, Coppel R . The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med. 1988; 167(6):1791-9. PMC: 2189671. DOI: 10.1084/jem.167.6.1791. View

Borchers A, Naguwa S, Keen C, Gershwin M . The implications of autoimmunity and pregnancy. J Autoimmun. 2009; 34(3):J287-99. DOI: 10.1016/j.jaut.2009.11.015. View

Cruickshank S, Southgate J, Selby P, Trejdosiewicz L . Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro. J Hepatol. 1998; 29(4):550-8. DOI: 10.1016/s0168-8278(98)80149-9. View

10.

Matsumura S, Van de Water J, Leung P, Odin J, Yamamoto K, Gores G . Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology. 2004; 39(5):1415-22. DOI: 10.1002/hep.20175. View

11.

Lucas M, Stuart L, Savill J, Lacy-Hulbert A . Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J Immunol. 2003; 171(5):2610-5. DOI: 10.4049/jimmunol.171.5.2610. View

12.

Mattalia A, Quaranta S, Leung P, Bauducci M, Van de Water J, Calvo P . Characterization of antimitochondrial antibodies in health adults. Hepatology. 1998; 27(3):656-61. DOI: 10.1002/hep.510270303. View

13.

Combes B, Emerson S, Flye N, Munoz S, Luketic V, Mayo M . Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatology. 2005; 42(5):1184-93. DOI: 10.1002/hep.20897. View

14.

Van de Water J, Turchany J, Leung P, Lake J, Munoz S, Surh C . Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest. 1993; 91(6):2653-64. PMC: 443329. DOI: 10.1172/JCI116504. View

15.

Agmon-Levin N, Shapira Y, Selmi C, Barzilai O, Ram M, Szyper-Kravitz M . A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun. 2009; 34(1):55-8. DOI: 10.1016/j.jaut.2009.08.009. View

16.

Hoffmann M, Trembleau S, Muller S, Steiner G . Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. J Autoimmun. 2009; 34(3):J178-206. DOI: 10.1016/j.jaut.2009.11.013. View

17.

Mandron M, Martin H, Bonjean B, Lule J, Tartour E, Davrinche C . Dendritic cell-induced apoptosis of human cytomegalovirus-infected fibroblasts promotes cross-presentation of pp65 to CD8+ T cells. J Gen Virol. 2007; 89(Pt 1):78-86. DOI: 10.1099/vir.0.83278-0. View

18.

Henson P . Dampening inflammation. Nat Immunol. 2005; 6(12):1179-81. DOI: 10.1038/ni1205-1179. View

19.

Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y . HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med. 1995; 181(5):1835-45. PMC: 2191998. DOI: 10.1084/jem.181.5.1835. View

20.

Ichiki Y, Selmi C, Shimoda S, Ishibashi H, Gordon S, Gershwin M . Mitochondrial antigens as targets of cellular and humoral auto-immunity in primary biliary cirrhosis. Clin Rev Allergy Immunol. 2005; 28(2):83-91. DOI: 10.1385/CRIAI:28:2:083. View